[application of 13- xxxd2404xxx  in patients with 131i scintigraphically-negative metastases of differentiated thyroid carcinoma].  the loss of iodine uptake by differentiated thyroid carcinoma (dtc) cells is a major therapeutic problem especially in patients with nonsurgical metastatic foci or local recurrence. using 13- xxxd2404xxx , it was attempted to retain iodine uptake as a result of redifferentiation (influence by  xxxd3417xxx  receptors present in dtc cells).